Cargando…

Incidence of pulmonary embolism during COPD exacerbation,

OBJECTIVE: Because pulmonary embolism (PE) and COPD exacerbation have similar presentations and symptoms, PE can be overlooked in COPD patients. Our objective was to determine the prevalence of PE during COPD exacerbation and to describe the clinical aspects in COPD patients diagnosed with PE. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Akpinar, Evrim Eylem, Hoşgün, Derya, Akpýnar, Serdar, Ataç, Gökçe Kaan, Doğanay, Beyza, Gülhan, Meral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075911/
https://www.ncbi.nlm.nih.gov/pubmed/24626268
http://dx.doi.org/10.1590/S1806-37132014000100006
_version_ 1782323419405090816
author Akpinar, Evrim Eylem
Hoşgün, Derya
Akpýnar, Serdar
Ataç, Gökçe Kaan
Doğanay, Beyza
Gülhan, Meral
author_facet Akpinar, Evrim Eylem
Hoşgün, Derya
Akpýnar, Serdar
Ataç, Gökçe Kaan
Doğanay, Beyza
Gülhan, Meral
author_sort Akpinar, Evrim Eylem
collection PubMed
description OBJECTIVE: Because pulmonary embolism (PE) and COPD exacerbation have similar presentations and symptoms, PE can be overlooked in COPD patients. Our objective was to determine the prevalence of PE during COPD exacerbation and to describe the clinical aspects in COPD patients diagnosed with PE. METHODS: This was a prospective study conducted at a university hospital in the city of Ankara, Turkey. We included all COPD patients who were hospitalized due to acute exacerbation of COPD between May of 2011 and May of 2013. All patients underwent clinical risk assessment, arterial blood gas analysis, chest CT angiography, and Doppler ultrasonography of the lower extremities. In addition, we measured D-dimer levels and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) levels. RESULTS: We included 172 patients with COPD. The prevalence of PE was 29.1%. The patients with pleuritic chest pain, lower limb asymmetry, and high NT-pro-BNP levels were more likely to develop PE, as were those who were obese or immobile. Obesity and lower limb asymmetry were independent predictors of PE during COPD exacerbation (OR = 4.97; 95% CI, 1.775-13.931 and OR = 2.329; 95% CI, 1.127-7.105, respectively). CONCLUSIONS: The prevalence of PE in patients with COPD exacerbation was higher than expected. The association between PE and COPD exacerbation should be considered, especially in patients who are immobile or obese.
format Online
Article
Text
id pubmed-4075911
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Sociedade Brasileira de Pneumologia e Tisiologia
record_format MEDLINE/PubMed
spelling pubmed-40759112014-07-16 Incidence of pulmonary embolism during COPD exacerbation, Akpinar, Evrim Eylem Hoşgün, Derya Akpýnar, Serdar Ataç, Gökçe Kaan Doğanay, Beyza Gülhan, Meral J Bras Pneumol Original Articles OBJECTIVE: Because pulmonary embolism (PE) and COPD exacerbation have similar presentations and symptoms, PE can be overlooked in COPD patients. Our objective was to determine the prevalence of PE during COPD exacerbation and to describe the clinical aspects in COPD patients diagnosed with PE. METHODS: This was a prospective study conducted at a university hospital in the city of Ankara, Turkey. We included all COPD patients who were hospitalized due to acute exacerbation of COPD between May of 2011 and May of 2013. All patients underwent clinical risk assessment, arterial blood gas analysis, chest CT angiography, and Doppler ultrasonography of the lower extremities. In addition, we measured D-dimer levels and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) levels. RESULTS: We included 172 patients with COPD. The prevalence of PE was 29.1%. The patients with pleuritic chest pain, lower limb asymmetry, and high NT-pro-BNP levels were more likely to develop PE, as were those who were obese or immobile. Obesity and lower limb asymmetry were independent predictors of PE during COPD exacerbation (OR = 4.97; 95% CI, 1.775-13.931 and OR = 2.329; 95% CI, 1.127-7.105, respectively). CONCLUSIONS: The prevalence of PE in patients with COPD exacerbation was higher than expected. The association between PE and COPD exacerbation should be considered, especially in patients who are immobile or obese. Sociedade Brasileira de Pneumologia e Tisiologia 2014 /pmc/articles/PMC4075911/ /pubmed/24626268 http://dx.doi.org/10.1590/S1806-37132014000100006 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Akpinar, Evrim Eylem
Hoşgün, Derya
Akpýnar, Serdar
Ataç, Gökçe Kaan
Doğanay, Beyza
Gülhan, Meral
Incidence of pulmonary embolism during COPD exacerbation,
title Incidence of pulmonary embolism during COPD exacerbation,
title_full Incidence of pulmonary embolism during COPD exacerbation,
title_fullStr Incidence of pulmonary embolism during COPD exacerbation,
title_full_unstemmed Incidence of pulmonary embolism during COPD exacerbation,
title_short Incidence of pulmonary embolism during COPD exacerbation,
title_sort incidence of pulmonary embolism during copd exacerbation,
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075911/
https://www.ncbi.nlm.nih.gov/pubmed/24626268
http://dx.doi.org/10.1590/S1806-37132014000100006
work_keys_str_mv AT akpinarevrimeylem incidenceofpulmonaryembolismduringcopdexacerbation
AT hosgunderya incidenceofpulmonaryembolismduringcopdexacerbation
AT akpynarserdar incidenceofpulmonaryembolismduringcopdexacerbation
AT atacgokcekaan incidenceofpulmonaryembolismduringcopdexacerbation
AT doganaybeyza incidenceofpulmonaryembolismduringcopdexacerbation
AT gulhanmeral incidenceofpulmonaryembolismduringcopdexacerbation